Aktiechat - investeringstips
Aktiesnakken
Genmab
Gubra
Bavarian Nordic
NOVO
TESLA
Zealand Pharma
Chemometec
Biotek-snakken
Amerikanske aktier
AI/Kunstig intelligens
Ennogie
Maersk
AMBU
ExpreS2ion
Pharma
Banker og Finans
EL-BILER
Grønne Aktier
Vestas
GN Store Nord
Laks
Shipping
Smallcap og First North aktier
Danske Bank
Hansa Biopharma
Medico
BITCOIN
OLIE OG GAS
Krypto
10/8 13:01 af Jan Van de Winkel |
cash is at 5.2 bn DKK......
| |
10/8 13:00 af Jan Van de Winkel |
expenses at 21% operating income at 582 mn which I s268% up since last year...
| |
10/8 13:00 af Jan Van de Winkel |
Key figures: revenue for H1 1024 mn kr 95% vs 2016...
| |
10/8 12:59 af Helge Larsen/PI-redaktør |
First of all let me congratulate on the great results for Q2 . Can you give us a short-term update on key figures and important events?
| |
10/8 12:59 af Jan Van de Winkel |
Looking forward. Thank you for hosting us.
| |
10/8 12:59 af Helge Larsen/PI-redaktør |
Jan van de Winkel and David Eatwell. Welcome to Q & A here on ProInvestor.com. We are very happy to have you back here and ready to answer questions from our investors.
| |
10/8 12:58 af Helge Larsen/PI-redaktør |
:-)
| |
10/8 12:57 af Jan Van de Winkel |
Yes, we are here. Looking forward to talking to you.
| |
10/8 12:57 af Helge Larsen/PI-redaktør |
Jan and David. Are you online?
|